Fukang Pharmaceutical Co., Limited

Fukang Pharmaceutical Co., Limited is a legitimate Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622) of Hong Kong on 2024-02-02 (operating for 2 years). According to the official register of the Hong Kong Companies Registry (CR), the entity holds an active statutory status of [Live / In Operation] (Statutory records last verified: September 2026).

The statutory identifiers for this corporation issued by Hong Kong SAR authorities are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [76191007] (effective from 27 December 2023, this 8-digit number serves as the official cross-departmental primary identifier and tax ID); 2. Company Registration Number (CRN): [3365690] (historical archive number issued by Companies Registry). In international banking KYC, trade bills of lading, and cross-border contracts, these two numbers uniquely confirm entity legitimacy.

Under Hong Kong law, incorporated companies do not maintain a 'legal representative' position; the Board of Directors exercises supreme statutory management authority. Under the New Inspection Regime of the Companies Ordinance, public inspection protects directors' personal identification by displaying correspondence addresses and masked ID numbers. To retrieve the complete certified directorship history, shareholding structure (Form NAR1), Significant Controllers Register (SCR), and multi-tier UBO beneficial ownership penetration, apply through 86hc.com for an official due diligence dossier.

According to the official statutory records of the Companies Registry, Fukang Pharmaceutical Co., Limited has officially recorded 1 legal name change(s): [Mingrentang Co., Limited (effective 2024-2-2)]. The current registered legal name was confirmed upon issuance of a Certificate of Change of Name by the Registrar of Companies. Screening former names is essential to uncover historical litigation and corporate credit track records.

Yes. 86hc.com comprehensively indexes the official filing registers of the Hong Kong Companies Registry, supporting verified retrieval of official statutory dossiers for this corporation. Pursuant to Section 107 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days of each incorporation anniversary. Available verified original dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and shareholders), Incorporation Form (Form NNC1/NC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A). Rapid document fulfillment within 15-30 minutes and Certified True Copies (CTC) signed by practicing Hong Kong CPAs are supported.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Officially licensed by Hong Kong statutory authorities, currently holding: Chinese Medicine Regulatory Office (CMRO) (Licence No. PW-2024-00066); Department of Health (DH Licensed Dealer) (Licence No. 64/2A/2025); 2. Judicial Screening (Litigation & Winding-Up): screening across the Court of Final Appeal, High Court, District Court, and Official Receiver's Office (ORO) shows no commercial claims and no active compulsory winding-up petitions on file.

The statutory registered office (corporate headquarters on official record) of Fukang Pharmaceutical Co., Limited is situated at: [ROOM 08, 10/F, BLOCK H, GOLDEN BEAR INDUSTRIAL CENTRE, 66-82 CHAI WAN KOK STREET, TSUEN WAN, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622) of Hong Kong, all companies registered in Hong Kong must maintain an official registered office within the Hong Kong SAR where official communications, regulatory notices, and legal court process may be lawfully served.

Under the Companies Ordinance (Cap. 622) and Business Registration Ordinance (Cap. 310) of Hong Kong, incorporated private corporations are not required to file or register an official website domain with the government. An entity's legal personality, operational validity, and authorized corporate status are established strictly through official statutory filings—such as the Certificate of Incorporation (CI), the latest Annual Return (Form NAR1), and the Business Registration Certificate issued by the Inland Revenue Department (BRN: 76191007). International trade partners, importers, and compliance officers are advised to verify statutory registry records rather than relying solely on self-published promotional websites.